Suvretta Capital Management, Llc - Nov 7, 2025 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Director, 10%+ Owner
Signature
Suvretta Capital Management, LLC; By: /s/Andrew Nathanson, General Counsel & Chief Compliance Officer
Stock symbol
BNTC
Transactions as of
Nov 7, 2025
Transactions value $
$19,999,994
Form type
4
Date filed
11/10/2025, 09:51 PM
Previous filing
Apr 2, 2025
SEC
View on sec.gov

Reporting Owners (4)

Name Relationship Address Signature Signature date CIK
SUVRETTA CAPITAL MANAGEMENT, LLC Director, 10%+ Owner 540 MADISON AVENUE, 7TH FLOOR, NEW YORK Suvretta Capital Management, LLC; By: /s/Andrew Nathanson, General Counsel & Chief Compliance Officer 2025-11-10 0001569064
Averill Madison Master Fund, Ltd. Director, 10%+ Owner C/O SUVRETTA CAPITAL MANAGEMENT, LLC, 540 MADISON AVENUE, 7TH FLOOR, NEW YORK Suvretta Capital Management, LLC; By: /s/Andrew Nathanson, General Counsel & Chief Compliance Officer 2025-11-10 0002021243
Averill Master Fund, Ltd. Director, 10%+ Owner C/O SUVRETTA CAPITAL MANAGEMENT, LLC, 540 MADISON AVENUE, 7TH FLOOR, NEW YORK Suvretta Capital Management, LLC; By: /s/Andrew Nathanson, General Counsel & Chief Compliance Officer 2025-11-10 0001939329
Cowen Aaron 10%+ Owner C/O SUVRETTA CAPITAL MANAGEMENT, LLC, 540 MADISON AVENUE, 7TH FLOOR, NEW YORK Suvretta Capital Management, LLC; By: /s/Andrew Nathanson, General Counsel & Chief Compliance Officer 2025-11-10 0001869640

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNTC Common stock, par value $0.0001 per share Purchase $9.86M +730K +8.29% $13.50 9.54M Nov 7, 2025 See footnotes F1, F2
transaction BNTC Common stock, par value $0.0001 per share Purchase $10.1M +751K +70.28% $13.50 1.82M Nov 7, 2025 See footnotes F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Notes are included on Exhibit 99.1.
F2 Notes are included on Exhibit 99.1.
F3 Notes are included on Exhibit 99.1.

Remarks:

Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information Exhibit 99.3 - Joint Filers' Signature